Articles from hc1

hc1, a leader in transforming actionable lab data into valuable insights that enable healthcare systems to close gaps in patient care and improve financial performance, and Shadowbox, an innovator in automation for independent labs, have announced a strategic partnership. This collaboration enables clinical laboratories that provide specialized, precision testing to serve health systems by proactively diagnosing and treating patients in a personalized manner. Bradley Bostic, Chairman and CEO of hc1, and Gregory A. Stein, Founder and CEO of Shadowbox, discuss the details and importance of this partnership in a recent episode of The Boombostic Health Podcast.

hc1 introduced today its new Outreach Optimization solution, designed to transform how clinical laboratories expand their outreach programs, strengthen provider relationships, and drive new revenue. This innovative program combines expert advisory services with advanced technology and connectivity tools to evaluate laboratory outreach efforts and deliver a tailored strategic plan that enhances efficiency and ensures measurable results.

hc1 today announced the launch of HerCare, an industry-first module within its MyBloodHealth platform designed to safeguard maternal health by identifying and addressing health risks associated with anemia in pregnancy. HerCare reflects the company’s commitment to technology that reveals vital health insights hidden in lab data, including those to enhance women's health and beyond.

hc1 introduced today its suite of Operational Excellence solutions, setting a new standard for laboratory efficiency and performance. By transforming lab data into actionable insights and automating workflows, hc1 Operational Excellence empowers health systems and commercial labs to reduce actual costs, increase efficiency and elevate diagnostic quality and service throughout a patient’s care journey, positioning the lab as a strategic asset in healthcare.

hc1, the leader in transforming lab data into actionable intelligence that improves patient health outcomes while boosting the bottom line, is accelerating growth with $6.25 million in new financing after a successful acquisition in October 2024 of Accumen. The funding will support launching enhanced solutions that couple hc1 + Accumen’s market-leading technology and expertise. This strategic growth initiative advances hc1’s mission of driving healthcare progress through predictive insights, personalized care, and increased efficiencies. Existing investor, Health Cloud Capital, led the investment with participation from health tech investment firm, A1 Health Ventures. Arsenal Capital Partners joined the investor base in the combined platform via its ownership stake in Accumen.

hc1, the healthcare information technology leader in improving patient care and reducing costs through real-time lab data insights, today announced it has acquired Accumen, a best-in-class healthcare performance consulting company based in Scottsdale, Arizona. Terms of the acquisition were not disclosed. The acquisition positions hc1 as the only comprehensive solution for transforming diagnostic labs into strategic assets for health systems.